Vamsi Kota

Associate Professor

  • 163 Citations
  • 7 h-Index
20102019
If you made any changes in Pure, your changes will be visible here soon.

Research Output 2010 2019

Filter
Article
2019

A case of chronic myelogenous leukemia occurring in a patient treated for essential thrombocythemia

Hassankrishnamurthy, S., Mody, M. D. & Kota, V., Jan 1 2019, In : American Journal of Case Reports. 20, p. 10-14 5 p.

Research output: Contribution to journalArticle

Essential Thrombocythemia
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Philadelphia Chromosome
Myeloproliferative Disorders
Primary Myelofibrosis

A retrospective study evaluating treatment patterns and survival outcomes in elderly patients with acute myeloid leukemia treated in the United States with either 7+3 or a hypomethylating agent

Bell, J. A., Galaznik, A., Farrelly, E., Blazer, M., Murty, S., Ogbonnaya, A., Eaddy, M., Fram, R. J., Faller, D. V. & Kota, V., Mar 1 2019, In : Leukemia Research. 78, p. 45-51 7 p.

Research output: Contribution to journalArticle

Acute Myeloid Leukemia
Retrospective Studies
Survival
Comorbidity
Confidence Intervals

Availability of all-trans retinoic acid and support systems for management of acute promyelocytic leukemia in Michigan and Louisiana, USA

Bolds, S. L., Hassan, S. M. K., Caprara, C. R., Debragga, S., Simon, K. S., Karkhanis, P., Gandhi, A., Jillella, A. & Kota, V., Jan 1 2019, In : Hematology Reports. 11, 2, p. 28-29 2 p., 7896.

Research output: Contribution to journalArticle

Open Access
Acute Promyelocytic Leukemia
Tretinoin
Clinical Protocols
Formularies
Directories
2018
2 Citations (Scopus)

Economic burden of elderly patients with acute myeloid leukemia treated in routine clinical care in the United States

Bell, J. A., Galaznik, A., Farrelly, E., Blazer, M., Murty, S., Ogbonnaya, A., Eaddy, M., Fram, R. J., Faller, D. V. & Kota, V., Aug 1 2018, In : Leukemia Research. 71, p. 27-33 7 p.

Research output: Contribution to journalArticle

Acute Myeloid Leukemia
Economics
Intensive Care Units
Costs and Cost Analysis
Inpatients
1 Citation (Scopus)

Patient characteristics, treatment patterns, and mortality in elderly patients newly diagnosed with ALL

Kim, C., Molony, J. T., Chia, V. M., Kota, V., Katz, A. J. & Li, S., Jan 1 2018, (Accepted/In press) In : Leukemia and Lymphoma.

Research output: Contribution to journalArticle

Open Access
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Mortality
Protein-Tyrosine Kinases
Drug Therapy
Therapeutics
2 Citations (Scopus)

Rhabdomyolysis following initiation of antiviral therapy with oseltamivir

Puttagunta, H., Alghsoon, S., Regula, P., Hassankrishnamurthy, S. & Kota, V., Jun 11 2018, In : American Journal of Case Reports. 19, p. 673-677 5 p.

Research output: Contribution to journalArticle

Oseltamivir
Rhabdomyolysis
Antiviral Agents
Respiratory Tract Infections
Human Influenza
15 Citations (Scopus)

Ruxolitinib: A steroid sparing agent in chronic graft-versus-host disease

Khoury, H. J., Langston, A. A., Kota, V., Wilkinson, J. A., Pusic, I., Jillella, A., Bauer, S., Kim, A. S., Roberts, D., Al-Kadhimi, Z., Bodo, I., Winton, E., Arellano, M. & Dipersio, J. F., Jul 1 2018, In : Bone marrow transplantation. 53, 7, p. 826-831 6 p.

Research output: Contribution to journalArticle

Graft vs Host Disease
Steroids
Janus Kinases
Allografts
Lung
2017
7 Citations (Scopus)

A novel immunohistochemical score to predict early mortality in acute myeloid leukemia patients based on indoleamine 2,3 dioxygenase expression

Mangaonkar, A., Mondal, A. K., Fulzule, S., Pundkar, C., Park, E. J., Jillella, A., Kota, V., Xu, H., Savage, N. M., Shi, H., Munn, D. H. & Kolhe, R. B., Dec 1 2017, In : Scientific Reports. 7, 1, 12892.

Research output: Contribution to journalArticle

Indoleamine-Pyrrole 2,3,-Dioxygenase
Acute Myeloid Leukemia
Mortality
Messenger RNA
Bone Marrow
6 Citations (Scopus)

Does the frequency of molecular monitoring after tyrosine kinase inhibitor discontinuation affect outcomes of patients with chronic myeloid leukemia?

Kong, J. H., Winton, E. F., Heffner, L. T., Chen, Z., Langston, A. A., Hill, B., Arellano, M., El-Rassi, F., Kim, A., Jillella, A., Kota, V., Bodó, I. & Khoury, H. J., Jul 1 2017, In : Cancer. 123, 13, p. 2482-2488 7 p.

Research output: Contribution to journalArticle

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Protein-Tyrosine Kinases
Reverse Transcriptase Polymerase Chain Reaction
Therapeutics
Confidence Intervals
3 Citations (Scopus)

Evaluation of romiplostim for the treatment of secondary failure of platelet recovery among allogeneic hematopoietic stem cell transplant patients

Hartranft, M. E., Clemmons, A. B., Deremer, D. L. & Kota, V., Jan 1 2017, In : Journal of Oncology Pharmacy Practice. 23, 1, p. 10-17 8 p.

Research output: Contribution to journalArticle

Hematopoietic Stem Cells
Treatment Failure
Blood Platelets
Transplants
Thrombopoietin Receptors
2 Citations (Scopus)

Managing acute promyelocytic leukemia in patients belonging to the Jehovah’s witness congregation

Jillella, A., Arellano, M. L., Heffner, L. T., Gaddh, M., Langston, A. A., Khoury, H. J., Mangoankar, A. & Kota, V., Sep 26 2017, In : Hematology Reports. 9, 3, p. 102-105 4 p., 7083.

Research output: Contribution to journalArticle

Jehovah's Witnesses
Acute Promyelocytic Leukemia
Mortality
Disseminated Intravascular Coagulation
Leukemia
7 Citations (Scopus)

Momelotinib in myelofibrosis: JAK1/2 inhibitor with a role in treating and understanding the anemia

Winton, E. F. & Kota, V., Feb 1 2017, In : Future Oncology. 13, 5, p. 395-407 13 p.

Research output: Contribution to journalArticle

Primary Myelofibrosis
Anemia
N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide
Inflammation
Neoplasms
1 Citation (Scopus)
Open Access
Drug interactions
prophylaxis
Rhabdomyolysis
Acute Myeloid Leukemia
medication
2 Citations (Scopus)

The safety of Bosutinib for the treatment of chronic myeloid leukemia

Kong, J. H., Khoury, H., Kim, A. S., Hill, B. G. & Kota, V., Oct 3 2017, In : Expert Opinion on Drug Safety. 16, 10, p. 1203-1209 7 p.

Research output: Contribution to journalArticle

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Protein-Tyrosine Kinases
Safety
Leukemia, Myeloid, Chronic Phase
Therapeutics
2016
2 Citations (Scopus)

Fosaprepitant for the prevention of nausea and vomiting in patients receiving BEAM or high-dose melphalan before autologous hematopoietic stem cell transplant

Clark, S. M., Clemmons, A. B., Schaack, L., Garren, J., Deremer, D. L. & Kota, V., Jan 1 2016, In : Journal of Oncology Pharmacy Practice. 22, 3, p. 416-422 7 p.

Research output: Contribution to journalArticle

fosaprepitant
Melphalan
Hematopoietic Stem Cells
Nausea
Vomiting
1 Citation (Scopus)

Prognostic value of complete remission with superior platelet counts in acute myeloid leukemia

Mangaonkar, A., Xu, H., Mohsin, J., Mansour, J., Chintalapally, R., Keen, R., Mondal, A. K., DeRemer, D., Clemmons, A. B., Clark, S. M., Shah, A., Jillella, A., Kolhe, R. B. & Kota, V., Feb 1 2016, In : Journal of Community and Supportive Oncology. 14, 2, p. 66-71 6 p.

Research output: Contribution to journalArticle

Platelet Count
Acute Myeloid Leukemia
Plasma Cells
Blood Platelets
Multivariate Analysis

Recurrent parotid carcinosarcoma in an asymptomatic patient

Mansour, J., Mangaonkar, A. & Kota, V., Jan 1 2016, In : Journal of Investigative Medicine High Impact Case Reports. 4, 4

Research output: Contribution to journalArticle

Carcinosarcoma
Surgery
surgery
Disease
Chemotherapy
2015
10 Citations (Scopus)

Predicting early blast transformation in chronic-phase chronic myeloid leukemia: Is immunophenotyping the missing link?

El Rassi, F., Bergsagel, J. D., Arellano, M., Gaddh, M., Jillella, A., Kota, V., Heffner, L. T., Winton, E. F. & Khoury, H. J., Jan 1 2015, In : Cancer. 121, 6, p. 872-875 4 p.

Research output: Contribution to journalArticle

Leukemia, Myeloid, Chronic Phase
Immunophenotyping
Lymphocyte Activation
Blast Crisis
Flow Cytometry
2 Citations (Scopus)

Utility and impact of early t(15;17) identification by Fluorescence In Situ Hybridization (FISH) in clinical decision making for patients in Acute Promyelocytic Leukemia (APL)

Kolhe, R. B., Mangaonkar, A., Mansour, J., Clemmons, A., Shaw, J., Dupont, B., Walczak, L., Mondal, A., Rojiani, A. M., Jillella, A. & Kota, V., 2015, In : International Journal of Laboratory Hematology. 37, 4, p. 515-520 6 p.

Research output: Contribution to journalArticle

Acute Promyelocytic Leukemia
Fluorescence In Situ Hybridization
Decision making
Fluorescence
Leukemia
2014
1 Citation (Scopus)

Acute facial paralysis and otomastoiditis as presenting symptoms of myeloid sarcoma

Howell, J., Segel, J., Jajosky, R., Savage, N. M., Fields, B., Kota, V. & Mowry, S., Aug 19 2014, (Accepted/In press) In : Otology and Neurotology.

Research output: Contribution to journalArticle

Mastoiditis
Myeloid Sarcoma
Second Primary Neoplasms
Facial Paralysis
Acute Myeloid Leukemia
2012
41 Citations (Scopus)

Intermediate-Dose versus Low-Dose Cyclophosphamide and Granulocyte Colony-Stimulating Factor for Peripheral Blood Stem Cell Mobilization in Patients with Multiple Myeloma Treated with Novel Induction Therapies

Hamadani, M., Kochuparambil, S. T., Osman, S., Cumpston, A., Leadmon, S., Bunner, P., Watkins, K., Morrison, D., Speir, E., DeRemer, D., Kota, V., Jillella, A., Craig, M. & Awan, F., Jul 1 2012, In : Biology of Blood and Marrow Transplantation. 18, 7, p. 1128-1135 8 p.

Research output: Contribution to journalArticle

Hematopoietic Stem Cell Mobilization
Granulocyte Colony-Stimulating Factor
Multiple Myeloma
Cyclophosphamide
Therapeutics
2010
3 Citations (Scopus)

Pancreatitis following administration of iodixanol in patients on hemodialysis: A pilot study

Kheda, M., Brenner, L., Riggans, D., Kota, V. & Szerlip, H. M., Jan 1 2010, In : Clinical Nephrology. 73, 5, p. 381-384 4 p.

Research output: Contribution to journalArticle

Pancreatitis
Renal Dialysis
Iohexol
Amylases
Lipase